− | '''Vaccination '''is avaliable and commonly used in the UK. Both vaccines avaliable in the UK are given intranasally and n<span style="font-weight: bold;"</span>either protect against re-infection when given during clinical outbreak, but can lessen the severity of the disease. There are also '''Inactivated''' vaccines: intranasal/intramuscular administration, which have a gE deletion making this a '''marker vaccine'''. There is an ELISA for gE deletion, which can enable culling of carrier animals. IPV has mostly been made obsolete by AI | + | '''Vaccination '''is avaliable and commonly used in the UK. Both vaccines avaliable in the UK are given intranasally and neither protect against re-infection when given during clinical outbreak, but can lessen the severity of the disease. There are also '''Inactivated''' vaccines: intranasal/intramuscular administration, which have a gE deletion making this a '''marker vaccine'''. There is an ELISA for gE deletion, which can enable culling of carrier animals. IPV has mostly been made obsolete by AI |